Intravesical chemotherapy in a controlled trial with thio-tepa versus doxorubicin hydrochloride. 1981

Y Horn, and A Eidelman, and N Walach, and M Ilian

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013852 Thiotepa A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed). Thio-Tepa,Thiophosphamide,Triethylenethiophosphoramide,AI3-24916,Girostan,NSC-6396,Tespa,Tespamin,Tris(1-aziridinyl)phosphine Sulfide,AI3 24916,AI324916,NSC 6396,NSC6396,Thio Tepa

Related Publications

Y Horn, and A Eidelman, and N Walach, and M Ilian
January 1987, Zhonghua fu chan ke za zhi,
Y Horn, and A Eidelman, and N Walach, and M Ilian
October 1967, The Journal of urology,
Y Horn, and A Eidelman, and N Walach, and M Ilian
April 1961, Folia haematologica; internationales Magazin fur Blutforschung,
Y Horn, and A Eidelman, and N Walach, and M Ilian
September 1980, Ugeskrift for laeger,
Y Horn, and A Eidelman, and N Walach, and M Ilian
April 1963, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
Y Horn, and A Eidelman, and N Walach, and M Ilian
January 1978, The Journal of urology,
Y Horn, and A Eidelman, and N Walach, and M Ilian
July 1979, The Journal of urology,
Y Horn, and A Eidelman, and N Walach, and M Ilian
December 1973, Journal d'urologie et de nephrologie,
Y Horn, and A Eidelman, and N Walach, and M Ilian
August 1986, Zhonghua wai ke za zhi [Chinese journal of surgery],
Copied contents to your clipboard!